Probing a Mosquito Protein for Clues in the Fight Against Zika

Article

As health departments around the U.S. boost efforts to combat Zika, scientists are working on new ways to kill the mosquitoes that carry the virus. One approach involves understanding the molecular mechanisms that keep the bugs alive so we can then undermine them. Scientists report in the ACS journal Biochemistry that they have revealed new structural insights on a key protein from Aedes aegypti, the mosquito species most often linked to the spread of Zika.
 
In February, the World Health Organization called for action against the disease after Brazil experienced a spike in the number of babies born with microcephaly, a condition characterized by an abnormally small head. Since then, the virus has been reported in more than 40 countries. Studies have shown that compounds that inhibit a protein called sterol carrier protein 2 (SCP2), which is involved in the transport of cholesterol and fats in insects, can kill Aedes aegypti larva. Kiran K. Singarapu and colleagues from CSIR - Indian Institute of Chemical Technology wanted to take a closer look at the structure of one of the protein's variants to help inform the development of future insecticides.
 
Using solution nuclear magnetic resonance, a technique that yields molecular-level information about proteins, the researchers were able to describe the 3-D structure and dynamics of a SCP2 variant. The new insights could help scientists screen small-molecule libraries for insecticide candidates. In addition to curbing Zika, any resulting compound that stamps out Aedes aegypti  could reduce cases of other illnesses - dengue fever, yellow fever and chikungunya - that the mosquito also carries.
 
The authors acknowledge funding from the Department of Science and Technology of India.

Source: American Chemical Society (ACS)

Recent Videos
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Association for Professionals in Infection Control and Epidemiology  (Image credit: APIC)
Lila Price, CRCST, CER, CHL, the interim manager for HealthTrust Workforce Solutions; and Dannie O. Smith III, BSc, CSPDT, CRCST, CHL, CIS, CER, founder of Surgicaltrey, LLC, and a central processing educator for Valley Health System
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Related Content